Flupentixol
From Wikipedia, the free encyclopedia
| Image:Flupenthixol.png | |
| Flupentixol
| |
| Systematic (IUPAC) name | |
| 2-[4-[3-[2-(trifluoromethyl)thioxanthen-9-ylidene] propyl]piperazin-1-yl]ethanol | |
| Identifiers | |
| CAS number | 2709-56-0 |
| ATC code | N05AF01 |
| PubChem | 17012 |
| DrugBank | APRD00388 |
| Chemical data | |
| Formula | C23H25F3N2OS |
| Mol. weight | 434.519 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 19 to 39 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
℞ Prescription only |
| Routes | Oral |
Flupenthixol is a synthetic compound that acts on a subset of dopamine receptors. It specifically antagonizes D1 and D2 dopamine receptors (as well as serotonin). Flupenthixol decanoate ester is used as an intramuscular depot injection as a long-acting antipsychotic, lasting up to 4 weeks from a single injection.

